Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
BASEL, Switzerland and BRIDGEWATER, N.J., Dec. 19, 2006 (PRIME NEWSWIRE) -- Speedel (SWX:SPPN) announced today that in the interests of patient safety it has stopped the current pivotal Phase III...
-
BASEL, Switzerland and BRIDGEWATER, N.J., Dec. 14, 2006 (PRIME NEWSWIRE) -- Speedel (SWX:SPPN) notes today's announcement by Novartis that the U.S. regulatory review period has been extended by up to...
-
BASEL, Switzerland and BRIDGEWATER, N.J., Nov. 29, 2006 (PRIME NEWSWIRE) -- Speedel (SWX:SPPN) today holds its annual Research & Development Day. The event is being held in Basel, and attended by...
-
BASEL, Switzerland and BRIDGEWATER, N.J., Nov. 17, 2006 (PRIMEZONE) -- Speedel (SWX:SPPN) today announced that it is very pleased with the Phase II clinical data on SPP200 in the treatment of 127...
-
BASEL, Switzerland and BRIDGEWATER N.J., Nov. 15, 2006 (PRIMEZONE) -- Speedel (SWX:SPPN) today announced financial results for the nine months ending September 30, 2006. Financial Highlights --...
-
BASEL, Switzerland and BRIDGEWATER, N.J., Oct. 31, 2006 (PRIMEZONE) -- Speedel (SWX:SPPN) announces that it has reached another significant milestone in the development of its family of renin...